{"id":36353,"title":"PCOS lifestyle program","title_html":"<p>PCOS lifestyle program<\/p>","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.bfq9jmz6","doi_status":2,"uri":"pcos-lifestyle-program-bfq9jmz6","type_id":1,"published_on":1591113968,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"created_on":1588149663,"categories":null,"creator":{"name":"Geranne Jiskoot","affiliation":null,"affiliations":[],"username":"m4tle1z1r1z4tle1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0233876","image":{"source":"\/img\/avatars\/007.png","placeholder":"\/img\/avatars\/007.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":"PLOS One","journal_name":"PLOS One","journal_link":"https:\/\/doi.org\/10.1371\/journal.pone.0233876","article_citation":"Jiskoot G,  Loos ADd,  Beerthuizen A,  Timman R,  Busschbach J,  Laven J (2020) Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial. PLoS ONE  15(6): e0233876. doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0233876\">10.1371\/journal.pone.0233876<\/a> ","public":1,"has_versions":0,"link":"https:\/\/doi.org\/10.1371\/journal.pone.0233876","total_collections":0,"number_of_steps":14,"authors":[{"name":"Geranne Jiskoot","affiliation":"Subdivision of Reproductive Medicine ","affiliations":[],"username":"m4tle1z1r1z4tle1","link":null,"image":{"source":"\/img\/avatars\/007.png","placeholder":"\/img\/avatars\/007.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"J.S.E Laven","affiliation":"Subdivision of Reproductive Medicine ","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"J.J. van Busschbach","affiliation":"Department of Medical Psychology and Psychotherapy","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"C. de Klerk","affiliation":"Department of Medical Psychology and Psychotherapy","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"J. de Niet","affiliation":"Department of Medical Psychology and Psychotherapy","affiliations":[],"username":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/pcos-lifestyle-program-bfq9jmz6","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"EA17DF4089F411EABDD6E3E78623C7C1","state_version_id":197,"steps":[{"id":928729,"guid":"B5D96EA089F511EABDD6E3E78623C7C1","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"D745024DDB674F7190BFEED4752CD90D","order_id":1,"type_id":6,"title":"Section","source":{"title":"Background"}},{"id":1054724,"guid":"382BE04BE24C4A0499D94F9C5CCC4517","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 5\u201310% of women in their reproductive years [<\/div><div class = \"text-block\"><a href=\"#_ENREF_1\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">1<\/span><\/a><\/div><div class = \"text-block\">]. According to the ESHRE\/ASRM Rotterdam consensus [<\/div><div class = \"text-block\"><a href=\"#_ENREF_2\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">2<\/span><\/a><\/div><div class = \"text-block\">], the diagnosis of PCOS requires at least 2 of the following 3 criteria: oligoovulation or anovulation (irregular or no menstrual cycle at all), clinical (hirsutism) and\/or biochemical signs of hyperandrogenism (elevated free androgen index or elevated testosterone levels), polycystic ovarian morphology (on ultrasound), and the exclusion of other aetiologies that might cause hyperandrogenism. PCOS women will generally experience one or more of the following symptoms in varying degrees: hirsutism (excessive body hair growth), acne, anovulatory infertility, obesity, insulin resistance and dyslipidaemia [<\/div><div class = \"text-block\"><a href=\"#_ENREF_2\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">2<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_3\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">3<\/span><\/a><\/div><div class = \"text-block\">]. <\/div><div class = \"text-block\">The incidence of overweight and obesity in PCOS women is between 50% and 60%[<\/div><div class = \"text-block\"><a href=\"#_ENREF_3\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">3<\/span><\/a><\/div><div class = \"text-block\">]. The prevalence of obesity in the general population is increasing, and this might result in an even higher incidence of PCOS in the future [<\/div><div class = \"text-block\"><a href=\"#_ENREF_4\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">4<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_5\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">5<\/span><\/a><\/div><div class = \"text-block\">]. The current prevalence of overweight and obesity is significantly higher in PCOS women, especially in Caucasian women [<\/div><div class = \"text-block\"><a href=\"#_ENREF_6\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">6<\/span><\/a><\/div><div class = \"text-block\">]. Overweight in women with PCOS negatively affects all clinical features [<\/div><div class = \"text-block\"><a href=\"#_ENREF_3\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">3<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_7\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">7-9<\/span><\/a><\/div><div class = \"text-block\">] and gaining weight aggravates also psychological aspects. Women with PCOS report a major impact on their quality of life (QoL) due to PCOS symptoms [<\/div><div class = \"text-block\"><a href=\"#_ENREF_10\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">10<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_11\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">11<\/span><\/a><\/div><div class = \"text-block\">] and experience more distress compared to women without PCOS [<\/div><div class = \"text-block\"><a href=\"#_ENREF_12\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">12<\/span><\/a><\/div><div class = \"text-block\">]. Weight concerns in particular appear to have the largest impact on QoL, compared to other PCOS symptoms such as amenorrhea, oligomenorrhea, hirsutism and acne [<\/div><div class = \"text-block\"><a href=\"#_ENREF_13\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">13<\/span><\/a><\/div><div class = \"text-block\">]. Obesity is also a risk factor for lower self-esteem and greater sexual dissatisfaction in women with PCOS, compared to age matched controls [<\/div><div class = \"text-block\"><a href=\"#_ENREF_14\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">14<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_15\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">15<\/span><\/a><\/div><div class = \"text-block\">]. PCOS women with amenorrhoea seem to have lower levels of self-esteem and greater fear of negative appearance compared to PCOS women with oligo-amenorrhea [<\/div><div class = \"text-block\"><a href=\"#_ENREF_16\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">16<\/span><\/a><\/div><div class = \"text-block\">]. <\/div><div class = \"text-block\">Whether PCOS women have a unique predisposition to obesity is not yet clear [<\/div><div class = \"text-block\"><a href=\"#_ENREF_17\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">17<\/span><\/a><\/div><div class = \"text-block\">]. A recent study by Louwers et al, looking into the genetic predisposition for overweight or obesity, did not discover any differences in the number of risk alleles for obesity between women with PCOS and the controls [<\/div><div class = \"text-block\"><a href=\"#_ENREF_18\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">18<\/span><\/a><\/div><div class = \"text-block\">]. Although women with PCOS generally do have a healthy diet, they seem to have a higher caloric intake and are physically less active, compared to controls without PCOS [<\/div><div class = \"text-block\"><a href=\"#_ENREF_19\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">19<\/span><\/a><\/div><div class = \"text-block\">]. Also, women diagnosed with PCOS more often use a self-initiated inadequate diet than controls [<\/div><div class = \"text-block\"><a href=\"#_ENREF_20\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">20<\/span><\/a><\/div><div class = \"text-block\">]. Insulin resistance might play a mediating role in the effect of obesity on metabolic and reproductive symptoms in PCOS [<\/div><div class = \"text-block\"><a href=\"#_ENREF_21\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">21<\/span><\/a><\/div><div class = \"text-block\">]. Other authors do suggest that the high prevalence of obesity might be a result of selection and referral bias of obese PCOS women [<\/div><div class = \"text-block\"><a href=\"#_ENREF_22\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">22<\/span><\/a><\/div><div class = \"text-block\">]. In summary, much about the link between PCOS and obesity remains unknown [<\/div><div class = \"text-block\"><a href=\"#_ENREF_1\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">1<\/span><\/a><\/div><div class = \"text-block\">]. It is still unclear whether obesity is the cause, or an effect of the disease itself [<\/div><div class = \"text-block\"><a href=\"#_ENREF_6\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">6<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_23\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">23<\/span><\/a><\/div><div class = \"text-block\">]. <\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:left\"><\/div><\/div><div class = \"text-block\">There is a large number of small (one or two-component) studies demonstrating that losing 5 to 10% of initial body weight improves reproductive, metabolic and psychological features in PCOS women [<\/div><div class = \"text-block\"><a href=\"#_ENREF_24\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">24<\/span><\/a><\/div><div class = \"text-block\">]. Moreover, it often leads to ovulation and subsequent pregnancy, [<\/div><div class = \"text-block\"><a href=\"#_ENREF_7\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">7<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_25\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">25-27<\/span><\/a><\/div><div class = \"text-block\">] as well as a reduction in miscarriage rates in PCOS women [<\/div><div class = \"text-block\"><a href=\"#_ENREF_4\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">4<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_7\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">7<\/span><\/a><\/div><div class = \"text-block\">]. Weight loss also reduces the risk of Type II Diabetes Mellitus and the incidence of the metabolic syndrome in the long term [<\/div><div class = \"text-block\"><a href=\"#_ENREF_7\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">7<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_27\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">27<\/span><\/a><\/div><div class = \"text-block\">]. Additionally, studies have indicated that decreasing intra-abdominal fat tissue in particular results in the restoration of ovulation [<\/div><div class = \"text-block\"><a href=\"#_ENREF_28\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">28<\/span><\/a><\/div><div class = \"text-block\">], even when women remain within their World Health Organisation (WHO) weight class after weight loss [<\/div><div class = \"text-block\"><a href=\"#_ENREF_29\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">29<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_30\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">30<\/span><\/a><\/div><div class = \"text-block\">].Recent work from Mutsaerts et al [<\/div><div class = \"text-block\"><a href=\"#_ENREF_31\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">31<\/span><\/a><\/div><div class = \"text-block\">] and Dokras et al [<\/div><div class = \"text-block\"><a href=\"#_ENREF_32\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">32<\/span><\/a><\/div><div class = \"text-block\">] showed different results. A mean weight loss of 4.4 kg following a two-component lifestyle treatment of 26 weeks did not result in a significant difference in live birth rates compared to a weight loss of 1.1 kg in the control group. Also, there was no difference in pregnancy and neonatal complications between groups [<\/div><div class = \"text-block\"><a href=\"#_ENREF_31\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">31<\/span><\/a><\/div><div class = \"text-block\">]. Weight loss by the Look AHEAD protocol (16 weeks) or the use of the oral contraceptive pill shows significant improvement in both groups at physicial and mental domains related to quality of life, depression and anxiety [<\/div><div class = \"text-block\"><a href=\"#_ENREF_32\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">32<\/span><\/a><\/div><div class = \"text-block\">]. At the ESHRE\/ASRM PCOS meeting in 2010, a consensus was reached that lifestyle should be optimized before conception [<\/div><div class = \"text-block\"><a href=\"#_ENREF_23\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">23<\/span><\/a><\/div><div class = \"text-block\">] to improve the effectiveness of fertility treatment [<\/div><div class = \"text-block\"><a href=\"#_ENREF_33\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">33<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_34\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">34<\/span><\/a><\/div><div class = \"text-block\">] and to improve (mental)health across a woman\u2019s lifespan as well as that of her child to be [<\/div><div class = \"text-block\"><a href=\"#_ENREF_27\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">27<\/span><\/a><\/div><div class = \"text-block\">]. However, no international evidence based protocol exists for the long-term treatment of overweight and obesity in this particular group of obese women [<\/div><div class = \"text-block\"><a href=\"#_ENREF_35\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">35<\/span><\/a><\/div><div class = \"text-block\">].<\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:left\"><\/div><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:left\">The biggest challenge in weight management programs is to achieve a reasonable and<\/div><\/div><div class = \"text-block\">sustainable weight loss [<\/div><div class = \"text-block\"><a href=\"#_ENREF_36\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">36<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_37\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">37<\/span><\/a><\/div><div class = \"text-block\">]. Many obesity interventions compare one-component (physical activity or nutrition intervention) with two-component (physical activity and nutrition or nutrition and counselling) interventions. Three-component (physical activity, nutrition and counselling) lifestyle interventions seems to have the biggest effect, compared to one or two components [<\/div><div class = \"text-block\"><a href=\"#_ENREF_38\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">38<\/span><\/a><\/div><div class = \"text-block\">]. Weight loss programs in general seem to be effective in the short term [<\/div><div class = \"text-block\"><a href=\"#_ENREF_39\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">39<\/span><\/a><\/div><div class = \"text-block\">]; however, most of the initial weight loss is regained within one year [<\/div><div class = \"text-block\"><a href=\"#_ENREF_36\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">36<\/span><\/a><\/div><div class = \"text-block\">]. Long term weight-loss seems the biggest challenge for the \u201cglobal obesity epidemic\u201d according to the WHO [<\/div><div class = \"text-block\"><a href=\"#_ENREF_40\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">40<\/span><\/a><\/div><div class = \"text-block\">]. Incorporating a healthy diet, increasing physical activity and changing dysfunctional thinking patterns in women with PCOS are key points in losing weight [<\/div><div class = \"text-block\"><a href=\"#_ENREF_41\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">41<\/span><\/a><\/div><div class = \"text-block\">].However, treatment adherence is often low [<\/div><div class = \"text-block\"><a href=\"#_ENREF_36\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">36<\/span><\/a><\/div><div class = \"text-block\">] and drop-out rates are high. The longer the treatment, the higher the chance for participants to drop-out, and indeed the highest dropout rates are reported in interventions that last 24 weeks or longer [<\/div><div class = \"text-block\"><a href=\"#_ENREF_42\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">42<\/span><\/a><\/div><div class = \"text-block\">]. This relation between the drop-out rate and the duration of therapy is particular worrying, as long lasting lifestyle changes are preferred. Patients who are likely to drop out will benefit most from adherence to a long-term lifestyle program compared to patients not at risk to drop out. Fauser et al. commented that more research is needed to optimize lifestyle interventions, maximizing weight loss and minimizing drop-out rates for PCOS women with a wish to conceive [<\/div><div class = \"text-block\"><a href=\"#_ENREF_23\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">23<\/span><\/a><\/div><div class = \"text-block\">]. <\/div><div class = \"text-block\">A possible solution to increase therapy adherence and reduce the drop-out rate is support by mobile phone applications. Weight loss interventions making use of internet and mobile phone applications have emerged to induce behavioural changes [<\/div><div class = \"text-block\"><a href=\"#_ENREF_43\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">43<\/span><\/a><\/div><div class = \"text-block\">]. There is a growing body of literature on Short Message Service (SMS) and smart phone interventions for obesity treatment, indicating that tailored text messages are more effective than generic ones [<\/div><div class = \"text-block\"><a href=\"#_ENREF_44\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">44<\/span><\/a><\/div><div class = \"text-block\">, <\/div><div class = \"text-block\"><a href=\"#_ENREF_45\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">45<\/span><\/a><\/div><div class = \"text-block\">]. Smart phone and mobile phone applications seem effective when embedded in an intervention program [<\/div><div class = \"text-block\"><a href=\"#_ENREF_46\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">46<\/span><\/a><\/div><div class = \"text-block\">]. Studies have indicated that sending SMS results in weight maintenance up to 12 months after completion of cognitive behavioural treatment (CBT), [<\/div><div class = \"text-block\"><a href=\"#_ENREF_47\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">47<\/span><\/a><\/div><div class = \"text-block\">] and supports controlling the desire to eat and promoting an active lifestyle [<\/div><div class = \"text-block\"><a href=\"#_ENREF_48\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">48<\/span><\/a><\/div><div class = \"text-block\">]. Moreover, the use of SMS has shown to improve adherence and decrease the drop-out rates in weight loss treatments [<\/div><div class = \"text-block\"><a href=\"#_ENREF_49\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">49<\/span><\/a><\/div><div class = \"text-block\">], which is associated with improvement in weight-related behaviours and weight outcomes [<\/div><div class = \"text-block\"><a href=\"#_ENREF_50\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">50<\/span><\/a><\/div><div class = \"text-block\">]. <\/div><div class = \"text-block\">Fauser et al. commented that more research is needed to optimize lifestyle interventions, maximizing weight loss and minimizing dropout for PCOS women with a wish to conceive [<\/div><div class = \"text-block\"><a href=\"#_ENREF_23\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">23<\/span><\/a><\/div><div class = \"text-block\">]. <\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928730,"guid":"C1CEF4A089F511EABDD6E3E78623C7C1","previous_id":928731,"previous_guid":"C902109089F511EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"A1E53BA384594FC891F5F5D8FAF51195","order_id":1,"type_id":6,"title":"Section","source":{"title":"Research hypothoses"}},{"id":1054724,"guid":"F320E94EF2A2408C89D12081039C82BC","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Primary:<\/div><div class = \"text-block\">1) A multidisciplinary 1-year cognitive-behavioural lifestyle<\/div><div class = \"text-block\">intervention (with or without SMS) is more effective to<\/div><div class = \"text-block\">decrease weight in 12 months, compared to usual care.<\/div><div class = \"text-block\">Secondary:<\/div><div class = \"text-block\">2) A multidisciplinary 1-year cognitive-behavioural<\/div><div class = \"text-block\">lifestyle intervention (with or without SMS) is<\/div><div class = \"text-block\">effective to decrease weight by 4.0 BMI points at<\/div><div class = \"text-block\">12 months, compared to usual care.<\/div><div class = \"text-block\">3) SMS maintenance treatment in combination with a<\/div><div class = \"text-block\">multidisciplinary 1-year cognitive-behavioural lifestyle<\/div><div class = \"text-block\">intervention is more effective than the multidisciplinary<\/div><div class = \"text-block\">1-year cognitive-behavioural lifestyle intervention alone,<\/div><div class = \"text-block\">in terms of weight loss maintenance and drop-out<\/div><div class = \"text-block\">reduction.<\/div><div class = \"text-block\">4) A multidisciplinary 1-year cognitive-behavioural<\/div><div class = \"text-block\">lifestyle intervention (with or without SMS) is<\/div><div class = \"text-block\">effective in improving the menstrual cyclicity as well <\/div><div class = \"text-block\">as anthropomorphometric, ultra-sonographic,<\/div><div class = \"text-block\">endocrine and psychological parameters in women<\/div><div class = \"text-block\">with PCOS.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#84CE84","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928731,"guid":"C902109089F511EABDD6E3E78623C7C1","previous_id":928729,"previous_guid":"B5D96EA089F511EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"75EF0B880AC14CD18D52AB8D35A190FF","order_id":1,"type_id":6,"title":"Section","source":{"title":"Aim"}},{"id":1054724,"guid":"364EDEB0F6A7478EBD1AF696136C9E31","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">The aim of this study is to examine whether CBT, provided<\/div><div class = \"text-block\">by a mental health professional working in a<\/div><div class = \"text-block\">multidisciplinary team with a dietician and a physical<\/div><div class = \"text-block\">therapist (a three-component intervention), is effective<\/div><div class = \"text-block\">to decrease weight, compared to usual care at the end of<\/div><div class = \"text-block\">treatment in obese women with PCOS. Furthermore, we<\/div><div class = \"text-block\">explore whether mobile phone applications are effective<\/div><div class = \"text-block\">in supporting behavioural change and sustainable<\/div><div class = \"text-block\">weight loss.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#94EBFF","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928734,"guid":"D8C17A6089F611EABDD6E3E78623C7C1","previous_id":928730,"previous_guid":"C1CEF4A089F511EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"4918711429D449EA9097856BDC506858","order_id":1,"type_id":6,"title":"Section","source":{"title":"Design"}},{"id":1054724,"guid":"40769F2DC2A8465CA408BCB0507E7E53","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">The present study is a longitudinal RCT measuring<\/div><div class = \"text-block\">the effectiveness of a three-component multidisciplinary<\/div><div class = \"text-block\">1-year cognitive-behavioural lifestyle intervention<\/div><div class = \"text-block\">in overweight\/obese women with PCOS. It is a threearmed<\/div><div class = \"text-block\">RCT comparing three groups: 1) CBT provided<\/div><div class = \"text-block\">by a multidisciplinary team or; 2) CBT provided by a<\/div><div class = \"text-block\">multidisciplinary team and Short Message Service<\/div><div class = \"text-block\">(SMS) or; 3) usual care: encouraged to lose weight by<\/div><div class = \"text-block\">publicly available services (control group), see Fig. 1. <\/div><div class = \"text-block\">Patients will be included in the trial at the department<\/div><div class = \"text-block\">of Obstetrics and Gynaecology of the Erasmus<\/div><div class = \"text-block\">MC in Rotterdam, the Netherlands.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928741,"guid":"1B926D9089F711EABDD6E3E78623C7C1","previous_id":928734,"previous_guid":"D8C17A6089F611EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"D5D6508EC53B461E83F8DE802805FBD3","order_id":1,"type_id":6,"title":"Section","source":{"title":"Design"}},{"id":1054724,"guid":"6DAD2027441448B09D7CA47580DA7344","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Participants<\/span><\/div><div class = \"text-block\">Women with menstrual cycle disorders are systematically<\/div><div class = \"text-block\">screened using the same standardised protocol i.e. the so<\/div><div class = \"text-block\">called CyclusOLigoAmenorroe (COLA) protocol. The<\/div><div class = \"text-block\">COLA protocol includes a family and reproductive history,<\/div><div class = \"text-block\">antropomorphometric, ultrasonographic assessments and<\/div><div class = \"text-block\">screening. Based on this screening, women are diagnosed<\/div><div class = \"text-block\">according the World Health Organisation (WHO) classification.<\/div><div class = \"text-block\">Women with WHO 2 normogonadotropic normoestrogenic<\/div><div class = \"text-block\">anovulation are further classified using the Rotterdam <\/div><div class = \"text-block\">consensus criteria for PCOS and non-PCOS.<\/div><div class = \"text-block\">Patients who meet the inclusion and exclusion criteria<\/div><div class = \"text-block\">(shown in Table 1) are eligible. At enrolment, all patients<\/div><div class = \"text-block\">receive detailed information about the role of weight loss in<\/div><div class = \"text-block\">PCOS and the benefits of lifestyle modification.<\/div><div class = \"text-block\">The gynaecologist presents the patient information<\/div><div class = \"text-block\">about the study using a patient information leaflet. After<\/div><div class = \"text-block\">2 weeks, patients are contacted by telephone in order to<\/div><div class = \"text-block\">assess whether they are willing to participate in the<\/div><div class = \"text-block\">study. In order to participate, patients need to sign the<\/div><div class = \"text-block\">informed consent form and return it by regular mail. As<\/div><div class = \"text-block\">soon as this form is received out our research office,<\/div><div class = \"text-block\">appointments for baseline measurements are made.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928742,"guid":"30315BD089F711EABDD6E3E78623C7C1","previous_id":928741,"previous_guid":"1B926D9089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"85A155EAEB094ABCB6F9BF1112E99C66","order_id":1,"type_id":6,"title":"Section","source":{"title":"Design"}},{"id":1054724,"guid":"9C3A87F4988542CAAC27131CF8DE916A","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Randomisation<\/span><\/div><div class = \"text-block\">At the baseline, after the initial assessment, participants<\/div><div class = \"text-block\">are randomized at a 2:1 ratio into the following groups:<\/div><div class = \"text-block\">1-year CBT lifestyle intervention with SMS (n = 78), 1-<\/div><div class = \"text-block\">year CBT lifestyle intervention without SMS (n = 78), or<\/div><div class = \"text-block\">the control group who receives usual care (n = 78) using<\/div><div class = \"text-block\">a computer-generated random numbers table. A research<\/div><div class = \"text-block\">nurse, who is not involved in the study, carries<\/div><div class = \"text-block\">out the randomisation. Assignment is made by sequentially<\/div><div class = \"text-block\">numbered, identical, sealed envelopes, each<\/div><div class = \"text-block\">containing a letter designating the allocation (i.e. \u201cA\u201d for<\/div><div class = \"text-block\">intervention with SMS, \u201cB\u201d for intervention without<\/div><div class = \"text-block\">SMS and \u201cC\u201d for control,).<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928743,"guid":"425251C089F711EABDD6E3E78623C7C1","previous_id":928742,"previous_guid":"30315BD089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"C48EA5C4F01A4B469A1B2921A14193D1","order_id":1,"type_id":6,"title":"Section","source":{"title":"Design"}},{"id":1054724,"guid":"233B849170364DE280D274DFC7B09FB9","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Intervention<\/span><\/div><div class = \"text-block\">The 1-year multidisciplinary lifestyle intervention aims at:<\/div><div class = \"text-block\">1) changing cognitions; 2) changing dietary habits; 3)<\/div><div class = \"text-block\">encouraging and promoting physical activity; and 4) activating<\/div><div class = \"text-block\">social support; and consists of twenty 2.5 h group<\/div><div class = \"text-block\">sessions. The first 1.5-h of every group session is supervised<\/div><div class = \"text-block\">by a mental health professional and a dietician. The<\/div><div class = \"text-block\">last hour of each session is supervised by a physical therapist.<\/div><div class = \"text-block\">Each lifestyle intervention group consists of a maximum<\/div><div class = \"text-block\">of 10 patients to ensure that there is sufficient<\/div><div class = \"text-block\">individual attention for every participant. Additionally, <\/div><div class = \"text-block\">participants receive five individual counselling sessions of<\/div><div class = \"text-block\">45 min with a mental health professional, five individual<\/div><div class = \"text-block\">sessions with a physical therapist and five with a dietician.<\/div><div class = \"text-block\">We developed the \u201cPCOS lifestyle textbook\u201d for participants,<\/div><div class = \"text-block\">which describes the activities of each group session<\/div><div class = \"text-block\">and the homework assignments. To standardize the treatment<\/div><div class = \"text-block\">and to facilitate the therapist\u2019s treatment adherence,<\/div><div class = \"text-block\">we developed a therapist manual, which includes protocols<\/div><div class = \"text-block\">for each session. The manual also includes Power-<\/div><div class = \"text-block\">Point slides to present at each group session.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928744,"guid":"55676BB089F711EABDD6E3E78623C7C1","previous_id":928743,"previous_guid":"425251C089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"2A21701C3E814DF7BA3BC3BADD10F5C9","order_id":1,"type_id":6,"title":"Section","source":{"title":"Design"}},{"id":1054724,"guid":"DEF4C649C78047A1BF327549BC841798","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Phase 1: first 3 months (session 1 to 11)<\/span><\/div><div class = \"text-block\">We divided the 20 group sessions into four phases. The<\/div><div class = \"text-block\">outline of each session is presented in Table 2. In the first<\/div><div class = \"text-block\">phase of the program, the group sessions are held weekly.<\/div><div class = \"text-block\">CBT techniques are used to create awareness and to<\/div><div class = \"text-block\">restructure dysfunctional thoughts about lifestyle (food &<\/div><div class = \"text-block\">exercise), weight (loss) and self-esteem. The Dutch food<\/div><div class = \"text-block\">guide (DFG) is used as a guideline for healthy eating and is<\/div><div class = \"text-block\">the main guideline during the nutritional sessions run by<\/div><div class = \"text-block\">the dietician. Subjects receive the DFG guide for women<\/div><div class = \"text-block\">aged 19 to 50 (Table 3) [51]. Based on the DFG, a healthy<\/div><div class = \"text-block\">woman with a normal weight and regular exercise, may<\/div><div class = \"text-block\">take in up to 2000 kilocalories in total, consisting of 1700<\/div><div class = \"text-block\">kilocalories for breakfast, lunch and dinner, and another<\/div><div class = \"text-block\">300 kilocalories for (healthy) snacking. The take-up of 2000<\/div><div class = \"text-block\">kilocalories in total is normally advised for weight maintenance.<\/div><div class = \"text-block\">Hence, for most women in the lifestyle program this<\/div><div class = \"text-block\">(reduced intake) will result in weight loss. During phase 1,<\/div><div class = \"text-block\">we emphasize that participants should start making healthy,<\/div><div class = \"text-block\">sustainable food choices and to avoid \u201crestrained\u201d behaviour<\/div><div class = \"text-block\">like skipping meals and reducing food variance [52].<\/div><div class = \"text-block\">The physical therapist encourages participants to use<\/div><div class = \"text-block\">exercise as part of their daily routine, [53] according to<\/div><div class = \"text-block\">the Global Recommendations for physical activity by the<\/div><div class = \"text-block\">World Health Organisation, [54] and advises:<\/div><div class = \"text-block\">\u2013 To do 5 days of moderate physical activity for<\/div><div class = \"text-block\">30 min each day; and<\/div><div class = \"text-block\">\u2013 To do vigorous exercise 1 to 3 days a week, for at<\/div><div class = \"text-block\">least 20 min per session; and<\/div><div class = \"text-block\">\u2013 To perform 8 to 10 muscle-strengthening activities<\/div><div class = \"text-block\">involving major muscle groups twice a week.<\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Phase 2: month 3 to 6 (session 12 to 16)<\/span><\/div><div class = \"text-block\">In the second phase of the program, the group sessions<\/div><div class = \"text-block\">are held once every two weeks. During this phase participants<\/div><div class = \"text-block\">are motivated to develop a structured eating pattern<\/div><div class = \"text-block\">to avoid over-restriction and under-restriction, like binge<\/div><div class = \"text-block\">eating and restrained eating [55]. The frequency of faceto-<\/div><div class = \"text-block\">face contact decreases over time, to stimulate participants<\/div><div class = \"text-block\">to maintain healthy eating and physical activity. This<\/div><div class = \"text-block\">is based on the principles of \u2018proactive coping\u2019 to promote <\/div><div class = \"text-block\">self-regulation [56]. Also, behavioural skills developed during<\/div><div class = \"text-block\">phase 1 of the intervention are reinforced [57].<\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Phase 3: month 6 to 9 (session 17 to 19)<\/span><\/div><div class = \"text-block\">In the third phase of the program, the group sessions are<\/div><div class = \"text-block\">held once a month. Participants learn about relapse management<\/div><div class = \"text-block\">and maintenance of their weight loss. By using<\/div><div class = \"text-block\">proactive coping, participants set new goals for the next 3 <\/div><div class = \"text-block\">months aimed at maintaining a healthy lifestyle. Individual<\/div><div class = \"text-block\">counselling sessions are planned if needed at the request<\/div><div class = \"text-block\">of the participant.<\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Phase 4: final 3 months (session 20)<\/span><\/div><div class = \"text-block\">During the final 3 months of the program, there are no<\/div><div class = \"text-block\">scheduled group sessions. Participants can contact the <\/div><div class = \"text-block\">multidisciplinary team if individual counselling sessions<\/div><div class = \"text-block\">are needed.<\/div><div class = \"text-block\">There is an outreach policy to motivate participants to<\/div><div class = \"text-block\">come to the measurement sessions, unless the participant<\/div><div class = \"text-block\">indicates to withdraw from the study. Participation<\/div><div class = \"text-block\">in the lifestyle intervention terminates if the participant<\/div><div class = \"text-block\">misses more than 3 out of 20 group sessions. In such<\/div><div class = \"text-block\">cases, the measurements will also stop. For obvious reasons,<\/div><div class = \"text-block\">the intervention and the measurements will also<\/div><div class = \"text-block\">stop when the participant is pregnant.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928745,"guid":"8A76082089F711EABDD6E3E78623C7C1","previous_id":928744,"previous_guid":"55676BB089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"94167196CC8A4A7A85921A5D1398F064","order_id":1,"type_id":6,"title":"Section","source":{"title":"Design"}},{"id":1054724,"guid":"AA069F5DE01E4422A19C4F8BE30DECF1","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Maintenance intervention by SMS<\/span><\/div><div class = \"text-block\">At the 3 month point, participants are randomly assigned<\/div><div class = \"text-block\">to SMS support or CBT without SMS support. Participants<\/div><div class = \"text-block\">will be sending weekly self-monitored information<\/div><div class = \"text-block\">regarding their diet, physical activity and emotions by<\/div><div class = \"text-block\">SMS to the mental health professional for the next<\/div><div class = \"text-block\">9 months (Table 4).<\/div><div class = \"text-block\">A semi-automated software program generates feedback<\/div><div class = \"text-block\">in response to the incoming messages. These feedback<\/div><div class = \"text-block\">messages provide social support, encourage positive<\/div><div class = \"text-block\">behaviour and empower behavioural strategies. The<\/div><div class = \"text-block\">mental health professional assesses whether the suggested<\/div><div class = \"text-block\">feedback is applicable before sending it to the participant.<\/div><div class = \"text-block\">In addition, participants receive two messages per week<\/div><div class = \"text-block\">addressing eating behaviour (self-monitoring, barriers,<\/div><div class = \"text-block\">binge eating, eating pace, emotional eating, food choices,<\/div><div class = \"text-block\">portions, planning, preparation, stimulus control, social<\/div><div class = \"text-block\">eating, sugar sweetened beverages) and physical activity<\/div><div class = \"text-block\">(motivation, fun facts, sedentary behaviour). There are five<\/div><div class = \"text-block\">types of messages, as shown in Table 5.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928746,"guid":"8F7A0F1089F711EABDD6E3E78623C7C1","previous_id":928745,"previous_guid":"8A76082089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"560DEE77E1A24DBCB377233576180D57","order_id":1,"type_id":6,"title":"Section","source":{"title":"Design"}},{"id":1054724,"guid":"88C0272306F249918BF1A053AB12DAEB","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Control group: usual care<\/span><\/div><div class = \"text-block\">Just like the lifestyle intervention group, the control<\/div><div class = \"text-block\">group visits the hospital after the initial assessment during<\/div><div class = \"text-block\">the 4 consecutive occasions at which they are similarly<\/div><div class = \"text-block\">assessed as the CBT lifestyle intervention group.<\/div><div class = \"text-block\">During these 5 measurement moments they have a<\/div><div class = \"text-block\">short, unstructured consult with their treating physician.<\/div><div class = \"text-block\">Participants in the control group are encouraged to lose <\/div><div class = \"text-block\">weight through publicly available services (i.e. diets, visiting<\/div><div class = \"text-block\">a dietician, going to the gym or participating in<\/div><div class = \"text-block\">public programs such as Weight Watchers\u00ae) and use<\/div><div class = \"text-block\">simple strategies, including self-monitoring of their diet.<\/div><div class = \"text-block\">The physician also mentions the risk of overweight for<\/div><div class = \"text-block\">both mother and child, and the relation between overweight<\/div><div class = \"text-block\">and fertility. If patients fail to achieve their target<\/div><div class = \"text-block\">weight during the 12-month study period (see below),<\/div><div class = \"text-block\">they can participate in the lifestyle intervention, but are<\/div><div class = \"text-block\">not included in the trial. <\/div><div class = \"text-block\">At the Erasmus MC, patients diagnosed with PCOS<\/div><div class = \"text-block\">receive ovulation induction treatment when shifted to a<\/div><div class = \"text-block\">lower BMI category. Meaning: 1) a weight loss of 4.0<\/div><div class = \"text-block\">BMI points; 2) a BMI < 34.0; and 3) weight loss maintenance<\/div><div class = \"text-block\">over 3 months. The intervention group receives<\/div><div class = \"text-block\">ovulation induction treatment after 1) a weight loss of<\/div><div class = \"text-block\">4.0 BMI points; 2) a BMI < 34.0; and 3) complying with<\/div><div class = \"text-block\">the intervention group for more than 1 year.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928753,"guid":"BBBF864089F711EABDD6E3E78623C7C1","previous_id":928746,"previous_guid":"8F7A0F1089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"926EE7CDE113486FBF1DB61157BFD63F","order_id":1,"type_id":6,"title":"Section","source":{"title":"Outcome measures"}},{"id":1054724,"guid":"E9D3F0ECD9B54A5482D0CCB180580C90","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">The primary outcome of this study is to test whether CBT<\/div><div class = \"text-block\">provided by a mental health professional, working in a<\/div><div class = \"text-block\">multidisciplinary team with a dietician and a physical therapist<\/div><div class = \"text-block\">(a three-component intervention), is effective to<\/div><div class = \"text-block\">decrease weight compared to usual care (control) at the<\/div><div class = \"text-block\">end of the treatment. <\/div><div class = \"text-block\">Secondary outcomes include: reproductive,<\/div><div class = \"text-block\">drop-out, quality of life, healthy diet, physical<\/div><div class = \"text-block\">activity, metabolic and endocrine improvements, the<\/div><div class = \"text-block\">health of the (unborn) child. All outcome variables are<\/div><div class = \"text-block\">measured at the start of the study, and again at 3 months,<\/div><div class = \"text-block\">6 months, 9 months and 12 months. All outcome measures<\/div><div class = \"text-block\">are displayed in Table 6. Below we give more details<\/div><div class = \"text-block\">about the collection of the secondary outcomes.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#EA9F6C","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928754,"guid":"D4DCF7C089F711EABDD6E3E78623C7C1","previous_id":928753,"previous_guid":"BBBF864089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"734D59D3AD65461B81B2E5664A366425","order_id":1,"type_id":6,"title":"Section","source":{"title":"Sample size"}},{"id":1054724,"guid":"6D637E81AD144F6C9423E5525907F066","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">The original sample size calculation in 2009 was based<\/div><div class = \"text-block\">on an anticipated effect of a difference between the<\/div><div class = \"text-block\">groups of 0.45 in terms of Cohen\u2019s d in the primary outcome<\/div><div class = \"text-block\">variable (BMI), with a power (1-beta) of 0.80 and<\/div><div class = \"text-block\">an alpha level of 0.05 (two-sided) in a 2:1 ratio. This ratio<\/div><div class = \"text-block\">was required for analysis of the secondary outcome:<\/div><div class = \"text-block\">the effect of SMS within the intervention group. This resulted<\/div><div class = \"text-block\">in 156 patients to be enrolled in the intervention<\/div><div class = \"text-block\">group and 78 patients in the control group, a total of 234. <\/div><div class = \"text-block\">This number was registered at the Dutch Trial<\/div><div class = \"text-block\">Registry (TC 2450). On behalf of the Grant Foundation<\/div><div class = \"text-block\">(MRace), an interim analysis was performed in May<\/div><div class = \"text-block\">2014. After inclusion of 150 patients, we applied an interim<\/div><div class = \"text-block\">power analysis to the complete cases. The control<\/div><div class = \"text-block\">group had a reduction from 33.3 \u00b1 6.8 kg\/m2 to 32.6 \u00b1<\/div><div class = \"text-block\">6.6 kg\/m2, an effect of Cohen\u2019s d = 0.10, whereas the lifestyle<\/div><div class = \"text-block\">intervention group showed a reduction from 33.8 \u00b1<\/div><div class = \"text-block\">4.8 kg\/m2 to 31.3 \u00b1 5.1 kg\/m2, an effect of d = 0.52 and a<\/div><div class = \"text-block\">difference of 0.42. For the sample size calculation, we<\/div><div class = \"text-block\">applied the method described by Aberson [71], with a<\/div><div class = \"text-block\">power of 0.90, a two-sided alpha of 0.025 (corrected for<\/div><div class = \"text-block\">the interim analysis) and five repeated measures linearly<\/div><div class = \"text-block\">decreasing. We observed an intercorrelation of about<\/div><div class = \"text-block\">0.90 between all measurements. Maintaining a ratio of<\/div><div class = \"text-block\">2:1, the required sample is 84 participants in the lifestyle<\/div><div class = \"text-block\">intervention and 42 in the control group, a total of 126<\/div><div class = \"text-block\">complete cases. With an observed drop-out proportion<\/div><div class = \"text-block\">of 40%, a total of 210 participants are needed for the<\/div><div class = \"text-block\">study. We anticipated to have a relatively high drop-out<\/div><div class = \"text-block\">rate, because pregnancy leads to exclusion. Note that<\/div><div class = \"text-block\">this sample size calculation is a conservative number, as<\/div><div class = \"text-block\">it is based on a complete case analysis of variance. The<\/div><div class = \"text-block\">intended multilevel analysis provides more power.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#E57785","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928756,"guid":"EEB9738089F711EABDD6E3E78623C7C1","previous_id":928754,"previous_guid":"D4DCF7C089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"D0F86C76FB75456D9FBEF83FB84D5CCE","order_id":1,"type_id":6,"title":"Section","source":{"title":"Statistical analyses"}},{"id":1054724,"guid":"1F01FDAD4121499A8A26777D1E4E5B8B","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Mixed modelling will be applied for longitudinal analyses of<\/div><div class = \"text-block\">the data by using SPSS version 21. Mixed modelling can efficiently<\/div><div class = \"text-block\">deal with missing data and unbalanced time-points<\/div><div class = \"text-block\">[72]. This analysis will include two levels: the patients will<\/div><div class = \"text-block\">constitute the upper level, and their repeated measures the<\/div><div class = \"text-block\">lower level. First, for each outcome variable a saturated<\/div><div class = \"text-block\">model will be postulated, with the primary or\/and secondary<\/div><div class = \"text-block\">outcomes as dependent variables. The saturated models<\/div><div class = \"text-block\">will include treatment group, time, quadratic time, logarithm<\/div><div class = \"text-block\">of time, and all treatment-time interactions as fixed<\/div><div class = \"text-block\">effects. The deviance statistic [73] using restricted<\/div><div class = \"text-block\">maximum likelihood [74] will be applied to determine the<\/div><div class = \"text-block\">covariance structure. Next, the saturated fixed part of the<\/div><div class = \"text-block\">models will be reduced by eliminating insignificant fixed<\/div><div class = \"text-block\">effects using Wald tests, respecting that interaction effects<\/div><div class = \"text-block\">must be nested under their main effects [75]. The significance<\/div><div class = \"text-block\">of the difference between the saturated models and<\/div><div class = \"text-block\">the parsimonious final models will be determined with the<\/div><div class = \"text-block\">deviance statistic using ordinary maximum likelihood. The<\/div><div class = \"text-block\">residuals of the model will be checked for normal distribution,<\/div><div class = \"text-block\">which is necessary for a correctly fitted mixed model.<\/div><div class = \"text-block\">Effect sizes will be calculated by dividing the differences<\/div><div class = \"text-block\">between time-point and baseline estimations and the estimated<\/div><div class = \"text-block\">baseline standard deviation. The definition of Cohen<\/div><div class = \"text-block\">will be used for the interpretation of the effects sizes: an<\/div><div class = \"text-block\">effect size of 0.20 is considered a small effect, 0.50 medium<\/div><div class = \"text-block\">and 0.80 a large effect [76].<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#EA94FF","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":928767,"guid":"DF99BA3089F811EABDD6E3E78623C7C1","previous_id":928756,"previous_guid":"EEB9738089F711EABDD6E3E78623C7C1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"CA2EF243163247F0875DB14DFD659484","order_id":1,"type_id":6,"title":"Section","source":{"title":"Citations"}},{"id":1054724,"guid":"FC1517E67F464CB187DA06FCDC8DA58D","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">References<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">1. Ehrmann, D.A., Polycystic ovary syndrome. N Engl J Med, 2005. 352(12): p. 1223-36.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">2. Rotterdam, E.A.-S.P.c.w.g., Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 2004. 19(1): p. 41-7.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">3. Laven, J.S., et al., New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv, 2002. 57(11): p. 755-67.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">4. Hoeger, K.M., Obesity and lifestyle management in polycystic ovary syndrome. Clin Obstet Gynecol, 2007. 50(1): p. 277-94.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">5. Dumesic, D.A., et al., Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev, 2015. 36(5): p. 487-525.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">6. Lim, S.S., et al., Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update, 2012. 18(6): p. 618-37.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">7. Clark, A.M., et al., Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod, 1995. 10(10): p. 2705-12.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">8. Broekmans, F.J., et al., PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG, 2006. 113(10): p. 1210-7.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">9. Valkenburg, O., et al., A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab, 2008. 93(2): p. 470-6.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">10. Kitzinger, C. and J. Willmott, 'The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med, 2002. 54(3): p. 349-61.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">11. McCook, J.G., N.E. Reame, and S.S. Thatcher, Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs, 2005. 34(1): p. 12-20.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">12. Veltman-Verhulst, S.M., et al., Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update, 2012. 18(6): p. 638-51.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">13. Jones, G.L., et al., Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review.Hum Reprod Update, 2008. 14(1): p. 15-25.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">14. Elsenbruch, S., et al., Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome.J Clin Endocrinol Metab, 2003. 88(12): p. 5801-7.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">15. Elsenbruch, S., et al., Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod, 2006. 21(4): p. 1092-9.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">16. de Niet, J.E., et al., Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod, 2010. 25(6): p. 1497-503.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">17. Hoeger, K.M. and S.E. Oberfield, Do women with PCOS have a unique predisposition to obesity? Fertil Steril, 2012. 97(1): p. 13-7.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">18. Louwers, Y.V., et al., BMI-associated alleles do not constitute risk alleles for polycystic ovary syndrome independently of BMI: a case-control study. PLoS One, 2014. 9(1): p. e87335.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">19. Moran, L.J., et al., The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod, 2013. 28(8): p. 2276-83.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">20. Huijgen, N.A., et al., Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity? PLoS One, 2015. 10(11): p. e0142772.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">21. Ara, R., et al., What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technol Assess, 2012. 16(5): p. iii-xiv, 1-195.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">22. Ezeh, U., B.O. Yildiz, and R. Azziz, Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab, 2013. 98(6): p. E1088-96.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">23. Fauser, B.C., et al., Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril, 2012. 97(1): p. 28-38 e25.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">24. Moran, L.J., et al., Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev, 2011(2): p. CD007506.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">25. Huber-Buchholz, M.M., D.G. Carey, and R.J. Norman, Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab, 1999. 84(4): p. 1470-4.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">26. Hoeger, K.M., et al., A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.Fertil Steril, 2004. 82(2): p. 421-9.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">27. Teede, H., A. Deeks, and L. Moran, Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med, 2010. 8: p. 41.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">28. Kuchenbecker, W.K., et al., In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is associated with resumption of ovulation. Hum Reprod, 2011. 26(9): p. 2505-12.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">29. Blackburn, G., Effect of degree of weight loss on health benefits. Obes Res, 1995. 3 Suppl 2: p. 211s-216s.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">30. Ross, R. and A.J. Bradshaw, The future of obesity reduction: beyond weight loss. Nat Rev Endocrinol, 2009. 5(6): p. 319-25.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">31. Mutsaerts, M.A., et al., Randomized Trial of a Lifestyle Program in Obese Infertile Women. N Engl J Med, 2016. 374(20): p. 1942-53.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">32. Dokras, A., et al., Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS. J Clin Endocrinol Metab, 2016. 101(8): p. 2966-74.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">33. Brewer, C.J. and A.H. Balen, The adverse effects of obesity on conception and implantation. Reproduction, 2010. 140(3): p. 347-64.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">34. Balen, A.H., et al., Should obese women with polycystic ovary syndrome receive treatment for infertility? Bmj, 2006. 332(7539): p. 434-5.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">35. Bates, G.W. and R.S. Legro, Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol, 2013. 373(1-2): p. 91-7.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">36. Norman, R.J., et al., Improving reproductive performance in overweight\/obese women with effective weight management. Hum Reprod Update, 2004. 10(3): p. 267-80.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">37. Wadden, T.A., et al., Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring), 2011. 19(10): p. 1987-98.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">38. Seo, D.C. and J. Sa, A meta-analysis of psycho-behavioral obesity interventions among US multiethnic and minority adults. Prev Med, 2008. 47(6): p. 573-82.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">39. Wadden, T.A., et al., Psychosocial and behavioral status of patients undergoing bariatric surgery: what to expect before and after surgery. Med Clin North Am, 2007. 91(3): p. 451-69, xi-xii.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">40. James, W.P., WHO recognition of the global obesity epidemic. Int J Obes (Lond), 2008. 32 Suppl 7: p. S120-6.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">41. Shaw, K., et al., Psychological interventions for overweight or obesity. Cochrane Database Syst Rev, 2005(2): p. CD003818.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">42. Mutsaerts, M.A., et al., Dropout is a problem in lifestyle intervention programs for overweight and obese infertile women: a systematic review. Hum Reprod, 2013. 28(4): p. 979-86.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">43. Fjeldsoe, B.S., A.L. Marshall, and Y.D. Miller, Behavior change interventions delivered by mobile telephone short-message service.Am J Prev Med, 2009. 36(2): p. 165-73.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">44. Dijkstra, A. and H. De Vries, The development of computer-generated tailored interventions. Patient Educ Couns, 1999. 36(2): p. 193-203.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">45. Ryan, P. and D.R. Lauver, The efficacy of tailored interventions. J Nurs Scholarsh, 2002. 34(4): p. 331-7.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">46. Shaw, R. and H. Bosworth, Short message service (SMS) text messaging as an intervention medium for weight loss: A literature review. Health Informatics J, 2012. 18(4): p. 235-50.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">47. Zwickert, K., et al., High or low intensity text-messaging combined with group treatment equally promote weight loss maintenance in obese adults. Obes Res Clin Pract, 2016. 10(6): p. 680-691.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">48. Joo, N.S. and B.T. Kim, Mobile phone short message service messaging for behaviour modification in a community-based weight control programme in Korea. J Telemed Telecare, 2007. 13(8): p. 416-20.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">49. de Niet, J., et al., Short message service reduces dropout in childhood obesity treatment: a randomized controlled trial.Health Psychol, 2012. 31(6): p. 797-805.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">50. Shapiro, J.R., et al., Text4Diet: a randomized controlled study using text messaging for weight loss behaviors. <\/span><\/a><\/div><div class = \"text-block\"><span>Prev Med, 2012. <\/span><span style = \"font-weight:bold;\">55<\/span><span>(5): p. 412-7.<\/span><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">51. Kok, F.J., et al., Richtlijnen goede voeding 2006. Den Haag: Gezondheidsraad, 2006.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">52. Lowe, M.R., et al., Restrictive dieting vs. \"undieting\" effects on eating regulation in obese clinic attenders. <\/span><\/a><\/div><div class = \"text-block\"><span>Addict Behav, 2001. <\/span><span style = \"font-weight:bold;\">26<\/span><span>(2): p. 253-66.<\/span><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">53. Hildebrandt, V.H., et al., Bewegen in Nederland 2000 2011. Trendrapport Bewegen en gezondheid, 2010. 2011.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">54. WHO, Global Recommendations on Physical Activity for Health. WHO Guidelines 2010.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">55. Telch, C.F., et al., Group cognitive-behavioral treatment for the nonpurging bulimic: an initial evaluation. J Consult Clin Psychol, 1990. 58(5): p. 629-35.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">56. Aspinwall, L.G. and S.E. Taylor, A stitch in time: self-regulation and proactive coping. Psychol Bull, 1997. 121(3): p. 417-36.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">57. Middleton, K.M., S.M. Patidar, and M.G. Perri, The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev, 2012. 13(6): p. 509-17.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">58. Strien, T.v., Frijters, J.E.R,. Bergers, G.P.A. & Defares, P.B, The Dutch Eating behavior Questionnaire (DEBQ) for Assesment of Retrained, Emotional and External Eating Behavior.International Journal of Eating Disorders, 1986. 5: p. 295-315.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">59. Fairburn, C.G. and S.J. Beglin, Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord, 1994. 16(4): p. 363-70.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">60. Ware, J.E., Jr. and C.D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 1992. 30(6): p. 473-83.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">61. Beck, A.T., et al., Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess, 1996. 67(3): p. 588-97.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">62. Association, A.P., Diagnostic and statistical manual of mental disorders: DSM-IV. 4 ed, in Washington, DC. 1994.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">63. Steer, R.A., et al., Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther, 1999. 37(2): p. 183-90.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">64. Schmitt, D.P. and J. Allik, Simultaneous administration of the Rosenberg Self-Esteem Scale in 53 nations: exploring the universal and culture-specific features of global self-esteem. J Pers Soc Psychol, 2005. 89(4): p. 623-42.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">65. Lundgren, J.D., D.A. Anderson, and J.K. Thompson, Fear of negative appearance evaluation: development and evaluation of a new construct for risk factor work in the field of eating disorders. Eat Behav, 2004. 5(1): p. 75-84.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">66. Burke, B.S., The dietary history as a tool in research. Journal of the American Dietetic Association, 1947. 23: p. 1041-1046.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">67. Van Staveren, W.A., J.O. De Boer, and J. Burema, Validity and reproducibility of a dietary history method estimating the usual food intake during one month. The American journal of clinical nutrition, 1985. 42(3): p. 554-559.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">68. Craig, C.L., et al., International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc, 2003. 35(8): p. 1381-95.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">69. Borg, G.A., Psychophysical bases of perceived exertion. Med sci sports exerc, 1982. 14(5): p. 377-381.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">70. Thomas, S., J. Reading, and R.J. Shephard, Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci, 1992. 17(4): p. 338-45.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">71. CL, A., Applied power analysis for the behavioral sciences. New York: Routledge, 2010.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">72. DB, L.R.R., Statistical analysis with missing data. New York: John Wiley and Sons, 1987.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">73. JB, S.J.W., Applied longitudinal data analysis - modeling change and event occurrence. Oxford: Oxford University Press, 2003.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">74. Verbeke G, M.G., Linear mixed models for longitudinal data. New York: Springer, 2000.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">75. J, H., Multilevel Analysis - Techniques and Applications. Mahwah, New Jersey: Erlbaum, 2002.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">76. Cohen, J., A power primer. Psychol Bull, 1992. 112(1): p. 155-9.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">77. Galtier-Dereure, F., et al., Choice of stimulation in polycystic ovarian syndrome: the influence of obesity. Hum Reprod, 1997. 12 Suppl 1: p. 88-96.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">78. Koning, A.M., et al., Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care. Hum Reprod Update, 2010. 16(3): p. 246-54.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">79. Green, M.A., et al., Who are the obese? A cluster analysis exploring subgroups of the obese. J Public Health (Oxf), 2016. 38(2): p. 258-64.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">80. Unick, J.L., et al., Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention. Obesity (Silver Spring), 2014. 22(7): p. 1608-16.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">81. Elfhag, K. and S. Rossner, Initial weight loss is the best predictor for success in obesity treatment and sociodemographic liabilities increase risk for drop-out. Patient Educ Couns, 2010. 79(3): p. 361-6.<\/span><\/a><\/div><div class = \"text-block\"><a href=\"\" style = \"text-decoration:underline;color:blue;cursor:pointer;\"><span style = \":;\">82. Carels, R.A., et al., Applying a stepped-care approach to the treatment of obesity. J Psychosom Res, 2005. 59(6): p. 375-83.<\/span><\/a><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":[],"critical_id":null,"duration":0}],"document":null,"materials":[],"description":"<div class = \"text-blocks\"><div class = \"text-block\">Obesity in women with polycystic ovary syndrome (PCOS)<\/div><div class = \"text-block\">negatively affects all clinical features, and a 5 to 10% weight<\/div><div class = \"text-block\">loss has shown promising results on reproductive, metabolic<\/div><div class = \"text-block\">and psychological level. Incorporating a healthy diet,<\/div><div class = \"text-block\">increasing physical activity and changing dysfunctional<\/div><div class = \"text-block\"><span>thought patterns in women with PCOS are ke<\/span><span style = \"font-weight:bold;\">y po<\/span><span>ints in<\/span><\/div><div class = \"text-block\">losing weight. The present study is a longitudinal randomized<\/div><div class = \"text-block\"><span>controlled trial (RCT) to study the effecti<\/span><span style = \"font-weight:bold;\">ven<\/span><span>ess of a<\/span><\/div><div class = \"text-block\">three-component 1-year cognitive-behavioural lifestyle<\/div><div class = \"text-block\">intervention in overweight\/obese women with PCOS. We<\/div><div class = \"text-block\">will also explore whether mobile phone applications are effective<\/div><div class = \"text-block\">in supporting behavioural change and sustainable<\/div><div class = \"text-block\">weight loss. The primary aim of the 12-month intervention<\/div><div class = \"text-block\">is to explore whether a three-component 1-year cognitivebehavioural<\/div><div class = \"text-block\">lifestyle intervention is effective to decrease<\/div><div class = \"text-block\">weight, when compared to usual care. We expect that CBT<\/div><div class = \"text-block\">provided by a multidisciplinary team, especially combined<\/div><div class = \"text-block\">with SMS, is effective in developing a healthy lifestyle and<\/div><div class = \"text-block\">achieving a long-term weight loss in women with PCOS.<\/div><div class = \"text-block\">Losing 5\u2013 10% body weight will improve various PCOS<\/div><div class = \"text-block\">characteristics. Consequently, we expect to show that CBT<\/div><div class = \"text-block\">provided by a multidisciplinary team improves reproductive<\/div><div class = \"text-block\">and metabolic outcomes, as well as quality of life, while at<\/div><div class = \"text-block\">the same time being cost-effective in women with PCOS.<\/div><\/div>","changed_on":1591113968}